What the analyst said
KeyBanc analyst Jackson Ader reiterated an Overweight rating and $300 price target on Oracle (NYSE: ORCL).
“Last Tuesday’s US Senate, congressional and gubernatorial side were a netnegative for Oracle’s OCI build (all summarized in the appendix), but in this note we’re going local. Below we lay out the most important results on a per-site basis across the 5 US mega-sites within the OCI portfolio but we really want to highlight the smaller results that may matter more.
For example, did you know the newly elected Doña Ana County, NM Commissioner (District 3) voted against allowing local governments to impose more strict environmental standards than the Federal government in 2021? You might want to.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
ORCL trades at $130. The 23 analysts who set a target in the last 3 months range from $155 to $400, with a median of $240. This $300 target is 25% above the median.
12-month window: day 1 of 365, closes on November 10, 2027.
Track record
This callOpen: ORCL has not reached $300 yet. This 12-month target is scored on November 10, 2027.
Firm track recordKeyBanc: 79% of its 24 targets at least a year old were reached within 12 months (#12 of 26 firms). Accuracy ranking →
KeyBanc on Oracle
KeyBanc price targets on Oracle
3 calls from March 11, 2026 to November 10, 2026. The target stayed at $300. The rating stayed Buy.
- November 10, 2026 This noteKept the $300 targetBuy$300
- June 11, 2026Kept the $300 targetBuy$300
- March 11, 2026Earliest call shownBuy$300
Other analysts on Oracle
BernsteinBuy
Kept rating and price targetReiterated · Nov 10
$325maintained
MizuhoBuy
Kept rating and price targetReiterated · Nov 9
$320maintained
ScotiabankBuy
Cut price target −5%, kept ratingCut target · Oct 29
$205from $215−5%
GuggenheimBuy
Kept rating and price targetReiterated · Oct 29
$400maintained
OppenheimerBuy
Kept rating and price targetReiterated · Oct 29
$275maintained